echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The registration and filing system of medical representatives has been implemented in succession throughout the country. When will the national version be released?

    The registration and filing system of medical representatives has been implemented in succession throughout the country. When will the national version be released?

    • Last Update: 2019-07-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [policies and regulations of pharmaceutical Station] in 2017, relevant departments drafted the measures for the administration of registration and filing of pharmaceutical representatives (Implementation) (Draft for comments), covering the definition of pharmaceutical representatives, employment content, requirements, qualifications, registration and filing methods, etc On May 8, 2018, Zhejiang hospital formulated the management system for registration and filing of medical (Mechanical) representatives of Zhejiang hospital (Trial), and issued the "work permit" to the medical representatives filed in July 2018 On May 13, 2018, Shaoxing maternal and child health care hospital issued relevant documents, indicating that it will register and record the medical representatives entering the hospital On May 18, 2018, Tianjin implemented the Interim Measures for reception of representatives of internal pharmaceutical production and operation enterprises of medical and health institutions in Tianjin, and proposed a more strict reception system of "three determinations and two haves" On January 2, 2019, nine departments including Guangdong health and Health Commission jointly issued a notice, mainly including standardizing the production and marketing of drug consumables, strengthening the supervision of medical services, promoting the filing management of medical representatives, etc Recently, the Affiliated Hospital of Jiujiang University held a meeting, and the vice president made it clear that the personnel engaged in the promotion and sales of medical devices and medical consumables in the hospital must implement the registration and filing system, carry out relevant business activities in accordance with the regulations of the municipal health and Health Commission and the hospital, and prohibit the promotion and promotion of medical devices and consumables in the outpatient (emergency) diagnosis and treatment places in the ward At the same time, the meeting also called for a firm end to the promotion and marketing of medical devices and consumables in illegal ways such as "kickback" or "Commission" We will severely crack down on commercial bribery in the field of pharmaceutical purchase and sale If we find any problems, we will never tolerate them, and we will investigate them to the end According to the analysis of the insiders, although the requirements of this time are mainly related to the equipment representatives, according to the past experience, the hospital will not specially "target" the medical equipment representatives If this trend is followed, the medical representatives will implement the same system in the near future The author understands that in recent years, the news about the coming of the national medical representative filing system has been circulating in the industry The latest news is that on August 23, 2018, nine ministries and commissions, including the national health and Health Commission, the National Health Insurance Bureau, the State Administration of market supervision and the Ministry of public security, jointly issued the key points of special governance work for correcting unhealthy tendencies in the field of medicine purchase and sale and medical services in 2018 (hereinafter referred to as "key points of work") The key points of work mentioned that this year (2018) will promote the implementation of the administrative measures for the filing of medical representatives (for Trial Implementation) According to the time schedule, a formal version of the filing system should have been introduced at this time, but the current situation is that the country continues to have hospitals to follow up, but it has not been implemented in a large area In this regard, some views say that even if there is a filing system, it will not immediately clean up the source, and all kinds of hidden interest transmission and rebate will exist for a long time Specifically, under the influence of a series of pharmaceutical policies, such as "4 + 7" volume purchase, Ministry of Finance Inspection and sales expenses, two vote system, etc., the space for pharmaceutical representatives to carry gold sales is constantly compressed, so the introduction of the filing system does not need to be so urgent at this time.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.